Unit
Kardiologie
KARDIO · Dept. I
CTO-R: Treatment of coronary chronic total occlusions (CTO) by percutaneous angioplasty (PCI): A single center registry
Jan 1, 2009The aim of the registry is to analyze clinical characteristics, angiographic and clinical follow-up of patients treated for a CTO by PCI. This will help to prove the clinical benefit for these patients. Furthermore we want to prove, that the MACE rat...
Clinical Studies - Jan 1, 2009 - Jan 1, 2013
Automatically Closed
Project leader: Weilenmann Daniel
Members: Jörg Lucas, Gemperle Michaela, Schneider Irene
RESOLUTE international: Evaluation des Endeavour Resolute Zotarolimus-Eluting-Koronarsystems in einer unselektionierten Patientenpopulation
Nov 7, 2008In dieser Studie soll die Sicherheit und Gesamtleistung des Zotarolimusfreisetzenden koronaren Stent-Systems Endeavour Resolute in einer unselektierten Patientenpopulation, bei der eine Stentimplantation erforderlich ist, aufgezeigt werden.
Clinical Studies - Nov 7, 2008 - May 31, 2012
Completed
Project leader: Rickli Hans
Members: Schefer Mirjam
TRA 2ºP-TIMI 50: Multizentrische, randomisierte, doppelblinde, placebokontrollierte Studie zur Beurteilung der Sicherheit und der Wirksamkeit von SCH 530348 bei Anwendung zusätzlich zur Standardtherapie bei Patienten mit anamnestisch bekannter Atherosklerose: Thrombin-Rezeptor-Antagonist zur Sekundärprophylaxe von atherothrombotischen ischämischen Ereignissen
Jul 18, 2008In dieser Studie soll der klinische Nutzen der Anwendung von SCH 530348 über mindestens ein Jahr zusätzlich zur Standardtherapie bei Patienten mit dokumentierter Atherosklerose untersucht werden. Primäres Ziel ist die Beurteilung der Fragestellung, o...
Clinical Studies - Jul 18, 2008 - Nov 30, 2010
Completed
Project leader: Rickli Hans
Members: Gemperle Michaela, Ehl Niklas, Geyer Reinhard
TRACER
Jul 18, 2008A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with acute Coronary Syndrome : Thrombin Receptor Antagonist for Clinical Event Reduction i...
Clinical Studies - Jul 18, 2008 - Oct 15, 2011
Completed
Project leader: Rickli Hans
ALTITUDE
Oct 24, 2007A randomized, double-blind, placebo-controlled, parallel-group study to determine whether, in patients with type 2 diabetes at high risk for cardiovascular and renal events, aliskiren, on top of conventional treatment, reduces cardiovascular and rena...
Clinical Studies - Oct 24, 2007 - Oct 24, 2011
Completed
Project leader: Rickli Hans
IMPROVE IT
Jan 24, 2006A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting with acute coronary Syndrome (IMProved Reduction of Outco...
Clinical Studies - Jan 24, 2006 - Aug 18, 2015
Completed
Project leader: Rickli Hans, Gemperle Michaela
Members: Bluzaite Ina
ORIGIN
Sep 1, 2004A Multicenter, International, Randomized, 2x2 factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) versus Standard Care, and of Omega-3 Fatty acids versus Placebo, in reducing cardiovascular Morbidity and Mortality, People with...
Clinical Studies - Sep 1, 2004 - Sep 1, 2008
Completed
Project leader: Brändle Michael, Rickli Hans
Members: Schefer Mirjam, Maier Margarete
AMIS -PLUS Register
Jan 1, 1997The AMIS Plus national registry collects and analyzes data on patients with acute coronary syndrome (acute myocardial infarction, unstable angina and minimal necrosis) in Switzerland in the pre-admission, hospital and follow-up phases. Emphasis is pl...
Clinical Studies - Jan 1, 1997 - Dec 31, 2030
Ongoing
Project leader: Rickli Hans
Members: Schneider Irene, Fink Karin